mktcap_usd=168598
ConsensRecom=2.00
earning_yield=2.63%
growth=12.32%
dilution=2.89%
div_ratio=44.24%
sh_payout_ratio=0
margin=10.43%
cfmargin=7.36%
ratiopaid=9.31%
sratiopaid=2.94%
ratioConsens=1.29
Description
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, womens health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2019-02-22 | 2019-02-22 | 2019-02-22 | 2020-02-21 | 2021-02-19 | 2022-02-18 | 2023-02-17 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 20853 | 27390 | 30578 | 31904 | 34608 | 43075 | 43653 | 33152 | 8201 |
| revgrowth | NaN | 27.27% | 11.01% | 4.25% | 8.14% | 21.89% | 1.33% | 12.31% | 10.20% |
| earn | 1400 | 477 | 2368 | 3687 | 4495 | 7071 | 6933 | 3776 | 2577 |
| earnx | 1063 | 1813 | 2464 | 3601 | 4497 | 7071 | 6933 | 3920 | 2386 |
| margin | 6.71% | 1.74% | 7.74% | 11.56% | 12.99% | 16.42% | 15.88% | 10.43% | 5.32% |
| xmargin | 5.10% | 6.62% | 8.06% | 11.29% | 12.99% | 16.42% | 15.88% | 10.91% | 4.47% |
| earningyld | 2.38% | 0.46% | 1.88% | 2.42% | 2.33% | 2.85% | 3.62% | 2.28% | 0.97% |
| cfop | 3203 | 5570 | 6300 | 6136 | 7901 | 10533 | 9581 | 7032 | 2505 |
| cfinv | -248 | -9618 | -1356 | -1815 | -2215 | -2008 | -1740 | -2714 | 3112 |
| cffin | 11147 | -5281 | -10391 | -4289 | -2779 | -5494 | -7636 | -3532 | 6921 |
| cfopmargin | 15.36% | 20.34% | 20.60% | 19.23% | 22.83% | 24.45% | 21.95% | 20.68% | 2.92% |
| cfinvmargin | -1.19% | -35.12% | -4.43% | -5.69% | -6.40% | -4.66% | -3.99% | -8.78% | 11.73% |
| cffinmargin | 53.46% | -19.28% | -33.98% | -13.44% | -8.03% | -12.75% | -17.49% | -7.36% | 28.04% |
| shares | 1461 | 1723 | 1744 | 1755 | 1760 | 1763 | 1738 | 1706 | 109 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 40.2 | 59.6 | 72.3 | 86.9 | 109 | 141 | 110 | 88.5 | 34.3 |
| dilution | NaN | 16.50% | 1.19% | 0.62% | 0.28% | 0.17% | -1.41% | 2.89% | 6.72% |
| dividend | 1539 | 1849 | 1974 | 2270 | 2560 | 3202 | 3309 | 2386 | 675 |
| sharebb | NaN | -13077 | -1365 | -863 | -484 | -370 | 3090 | -2178 | 5569 |
| ltdebtbb | NaN | -6529 | 7851 | 3244 | -2412 | 1231 | 2774 | 1026 | 4970 |
| mgtbb | NaN | -23038 | -1931 | 362 | -3115 | -1431 | 1537 | -4602 | 9183 |
| divyld | 2.62% | 1.80% | 1.57% | 1.49% | 1.33% | 1.29% | 1.73% | 1.69% | 0.45% |
| sharebbyld | NaN | -16.50% | -1.19% | -0.62% | -0.28% | -0.17% | 1.41% | -2.89% | 6.72% |
| mgtyld | NaN | -22.43% | -1.53% | 0.24% | -1.62% | -0.58% | 0.80% | -4.18% | 8.99% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2019-02-22 | 2019-02-22 | 2019-02-22 | 2020-02-21 | 2021-02-19 | 2022-02-18 | 2023-02-17 | NaN | NaN |
| mktcap | 58707 | 102727 | 126133 | 152413 | 192661 | 248065 | 191470 | 153168 | 63549 |
| mktcapgrowth | NaN | 55.95% | 20.53% | 18.93% | 23.43% | 25.28% | -25.90% | 19.70% | 26.23% |
| totAsset | 52666 | 76250 | 67173 | 67887 | 72548 | 75196 | 74438 | 69451 | 8196 |
| assetgrowth | NaN | 37.00% | -12.67% | 1.06% | 6.64% | 3.58% | -1.01% | 5.77% | 16.67% |
| curAsset | 26776 | 20147 | 14632 | 15667 | 20441 | 24239 | 25224 | 21018 | 4686 |
| curAssetPct | 50.84% | 26.42% | 21.78% | 23.08% | 28.18% | 32.23% | 33.89% | 30.92% | 9.83% |
| totLiab | 32128 | 45353 | 36649 | 36799 | 39764 | 39394 | 37752 | 38263 | 4009 |
| totLiabPct | 61.00% | 59.48% | 54.56% | 54.21% | 54.81% | 52.39% | 50.72% | 55.31% | 3.68% |
| curLiab | 6660 | 8912 | 9012 | 10863 | 11907 | 13105 | 15489 | 10850 | 2956 |
| curLiabPct | 12.65% | 11.69% | 13.42% | 16.00% | 16.41% | 17.43% | 20.81% | 15.49% | 3.16% |
| ltDebt | 20681 | 27210 | 19359 | 16115 | 18527 | 17296 | 14522 | 19101 | 4119 |
| ltDebtPct | 39.27% | 35.69% | 28.82% | 23.74% | 25.54% | 23.00% | 19.51% | 27.94% | 7.16% |
| Equity | 20538 | 30897 | 30524 | 31088 | 32784 | 35802 | 36686 | 31188 | 5292 |
| EquityPct | 39.00% | 40.52% | 45.44% | 45.79% | 45.19% | 47.61% | 49.28% | 44.69% | 3.68% |
| PB | 2.86 | 3.32 | 4.13 | 4.90 | 5.88 | 6.93 | 5.22 | 4.75 | 1.43 |
Beta
len=92.0
mean=11.78%
sd=18.40%
alpha=0.53%
beta=65.07%
r_sq=38.77%
lastdate=2023-03-17
firstdate=2016-05-31
logret1y=-19.89%
Financial Snapshot
CompanyName=Abbott Laboratories
ID=1
Name=Ordinary Shares
Ticker=ABT
ISIN=None
RIC=ABT
DisplayRIC=ABT.N
InstrumentPI=258450
QuotePI=1089457
InstrumentPermID=8590938522
QuotePermID=55838319606
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-06
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=115000
SharesOut=1.738e+09
TotalFloat=1.731e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Medical Equipment, Supplies & Distribution (NEC)
IndustryCode=5610102010
NPRICE=97.0
NHIG=124
NLOW=93.2
PDATE=2023-03-17
VOL10DAVG=6.33
EV=175201
MKTCAP=168598
AREV=43653
AEBITD=11740
ANIAC=6933
AEPSXCLXOR=3.93
AREVPS=24.7
ABVPS=21.1
ACSHPS=5.85
ACFSHR=5.78
ADIVSHR=1.88
AGROSMGN=56.1
AROEPCT=19.1
APR2REV=3.86
APEEXCLXOR=24.7
APRICE2BK=4.60
ConsRecom=2.00
TargetPrice=125
ProjLTGrowthRate=8.30
ProjPE=22.0
ProjSales=40070
ProjSalesQ=9642
ProjEPS=4.40
ProjEPSQ=98.77%
ProjProfit=7725
ProjDPS=1.91
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=ABT
exchg=AMEX
RIC=ABT
CompanyName=Abbott Laboratories
ExchangeCode=NYSE
Industry=Medical Equipment, Supplies & Distribution (NEC)
IndustryCode=5610102010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=168598
float_usd=167902
ConsensRecom=2.00
earning_yield=2.63%
growth=12.32%
dilution=2.89%
margin=10.43%
searning_yield=1.39%
sgrowth=3.00%
smargin=5.51%
sdilution=9.03%
projearning_yield=4.44%
earning_excl_yield=3.97%
div_ratio=44.24%
bb_ratio=-1.09
sh_payout_ratio=0
PS=3.92
price=97.0
ratio=25.10%
sratio=5.76%
sratiopaid=2.94%
ratioConsens=1.29
turnover=47.38%
cfmargin=7.36%
rdmargin=7.07%
scfmargin=-18.60%
quoteccy=USD
quotefx=100.00%
ratiopaid=9.31%
dt=2023-03-17
assetgrowth=5.77%
dlnfx=0